Navigation Links
Pfizer, Merck, Roche/Genentech, GSK, J&J, BMS and More to Speak at Contracting & Outsourcing 2010
Date:9/16/2010

NEW BRUNSWICK, N.J., Sept. 15 /PRNewswire/ -- On Sept. 23 and 24, the Hyatt Regency in New Brunswick, N.J. will host Contracting & Outsourcing 2010, the 9th annual Conference and Tabletop Exhibition held by Contract Pharma Magazine. This year's Conference will feature a keynote presentation by Mac Lynch, Vice President, Contract Manufacturing at Pfizer, covering Global Pharma Outsourcing Trends. Other speakers and panelists represent FDA, Johnson & Johnson, Roche/Genentech, Bristol-Myers Squibb, Merck, GlaxoSmithKline and more.

Contracting & Outsourcing 2010 will feature presentations and panels discussing a wide array of pharma and biopharma outsourcing and contract service topics, including far east outsourcing, sponsor-provider partnerships, CMO management, FDA compliance enforcement, clinical trial management, inspection issues and more. The conference will also include a panel on Contract Laboratory Criteria and the inaugural Executive Outsourcing Summit, with participants from across the drug development spectrum.

The event will feature a one-day Tabletop Exhibition on Sept. 23. With 160 contract service providers and vendors in attendance, the Exhibit Hall will cover virtually every aspect of the drug development and commercialization continuum.

Networking opportunities are enhanced by a Cocktail Reception at the end of the first day. Sponsored by Catalent Pharma Solutions, the reception offers an informal atmosphere for conversation and deal-making. The mix of presentations and exhibitions promises value to attendees from large pharma and biopharma companies as well as those from emerging and startup firms.

A full list of exhibitors can be found at http://contractpharma.com/2010conference/exhibitor_list

The schedule for Contracting & Outsourcing, as well as bios of all speakers, can be found at

SOURCE Contract Pharma Magazine
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. WWMR Announces Pain Clinic Physicians Most Appreciated Companies: Pfizer, Eli Lilly and Endo Pharmaceuticals
2. Lakewood-Amedex, Inc. Appoints William J. Robison, Former Executive Vice President of Pfizer, as Board Member
3. Oramed Pharmaceuticals Announces That Dr. Michael Berelowitz, Senior Vice President at Pfizer, Joins its Board of Directors
4. Neuralstem CEO to Speak on ALS Panel at World Stem Cell Summit
5. Accuray Incorporateds CEO to Speak at UBS Global Life Sciences Conference
6. MedNet Solutions to Speak, Sponsor and Exhibit at the 2008 Society of Clinical Data Management Annual Conference in Dallas
7. Former Speaker of the House Newt Gingrich Featured Wednesday
8. Brain and Hearing Pioneer, Michael Merzenich, Ph.D. to Speak at Case Western Reserve University
9. Verenium Corporation to Speak at the Credit Suisse Alternative Energy Conference
10. Dr. Gail Naughton Speaks on Histogen's Business Plan and the Rise of Bioaesthetic Medicine during Commercial Translation of Regenerative Medicine
11. Varian, Inc. CEO to Speak at the Nasdaq OMX 22nd Investor Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Dec. 22, 2014  ( www.competitivehealth.com ) — Competitive ... medical bill review and advocacy service, has signed an ... WellCard Savings discount health services marketplace. 63% ... more than they expected to pay. As part of ... costs, WellCard Savings is pleased to offer medical bill ...
(Date:12/22/2014)... 22, 2014 Fertility Associates of Memphis ... Bank USA , a network of more than 20 ... partnership, patients have fast access to a national pool ... IVF . Fertility Associates of Memphis is the only ... treatment option. , Dr. William Kutteh , director ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one ... of Nick Maroulis, Pharm.D. to the newly created position ... In this position, Dr. Maroulis will continue to manage ... of our multi-site pharmacies as the company expands. Dr. ... that time he has served in many different capacities ...
(Date:12/19/2014)... Dec. 19, 2014 Bina Technologies, Inc. (Bina, ... that they have been acquired by Roche (SIX: RO, ... privately held company that provides a big data platform ... (NGS) data for the academic and translational research markets. ... and will continue to focus on development of their ...
Breaking Biology Technology:WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... , , HOPKINTON, Mass., July 30 ... reported that for the second quarter of 2009 revenues were $32.1 ... Divestitures and foreign currency translation negatively impacted comparative revenues by ... The Company narrowed its net loss to $4.1 million ($0.08 per ...
... TOKYO, July 30 With a business plan to launch ... subsidiary of,the Zydus group, one of India,s leading integrated pharma ... big boost to its operations,in the Japanese generic market which ... estimated at $ 60 bn the generic market is only,about ...
... PLEASANTON, Calif., FRAMINGHAM, Mass. and SYDNEY, ... a world leader in device-based mechanical circulatory support therapies to ... (Nasdaq: HTWR ; ASX: HIN), which develops and ... States Federal Trade Commission ("FTC") has informed them that the ...
Cached Biology Technology:Caliper Life Sciences Reports Second Quarter 2009 Results 2Caliper Life Sciences Reports Second Quarter 2009 Results 3Caliper Life Sciences Reports Second Quarter 2009 Results 4Caliper Life Sciences Reports Second Quarter 2009 Results 5Caliper Life Sciences Reports Second Quarter 2009 Results 6Caliper Life Sciences Reports Second Quarter 2009 Results 7Caliper Life Sciences Reports Second Quarter 2009 Results 8Caliper Life Sciences Reports Second Quarter 2009 Results 9Caliper Life Sciences Reports Second Quarter 2009 Results 10"Over the Next 2-3 Years We Will Leverage Developmental Capabilities and Explore In-licensing and a Co-development Model to Consolidate Our Presence in Japan" - Dr. Kailash Sharma, President, Japan Operations, Zydus Cadila 2U.S. Federal Trade Commission to Challenge Thoratec's Proposed Acquisition of HeartWare International 2U.S. Federal Trade Commission to Challenge Thoratec's Proposed Acquisition of HeartWare International 3U.S. Federal Trade Commission to Challenge Thoratec's Proposed Acquisition of HeartWare International 4
(Date:12/22/2014)... 22, 2014 Research and Markets ... addition of the "The Global Watermarking ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... overview of the global digital media watermarking ... and monitor piracy by securely and invisibly ...
(Date:12/19/2014)... , Dec. 18, 2014   LaunchKey , ... for the post-password and Internet of Things era, today ... funding. The venture round was led by Metamorphic Ventures ... Rimrock Venture Partners, VegasTechFund, and others.  LaunchKey has raised ... funding to expand its team and bring LaunchKey to ...
(Date:12/17/2014)... Dec. 16, 2014 Research and Markets ... of the "Global Chemical Sensor Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 One major ... demand for medical sensors in biomedical applications. Chemical ... quick and correct diagnosis during surgical procedures. The ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
... Respiratory syncytial virus (RSV) infection is a widespread infant illness ... but may be curable by the development of this new ... and The University of Queensland's Faculty of Biological and Chemical ... cost millions of dollars a year in health care in ...
... by just 1.2 percent, yet there is a considerable difference ... A new study showed that a certain form of neuropsin, ... is expressed only in the central nervous systems of humans ... The study, which also demonstrated the molecular mechanism that creates ...
... immune system component that is a primary cause of ... rheumatoid arthritis actually protects bone in the oral cavity ... periodontal disease in humans, research at the University at ... only in the past 18 months to be a ...
Cached Biology News:UQ research heralds vaccine technology breakthrough 2Gene mutation linked to cognition is found only in humans 2Molecule that destroys bone also protects it, new research shows 2Molecule that destroys bone also protects it, new research shows 3
Human Cell Line Slides...
... Each Signet Level 2 Detection ... the avidin-biotin chemical bonding principle and ... to provide sensitivity, specificity and reliablility. ... immunostaining in both manual and automated ...
Mouse monoclonal [3576] to Yellow Fever Virus ( Abpromise for all tested applications). Antigen: Tissue / cell preparation...
... Level 2 Detection System combines the ... bonding principle and Signets unique formulation ... specificity and reliablility. Signet reagents will ... manual and automated protocols. ,Signets ...
Biology Products: